Abstract:ABSTRACT Avilamycins, which possess potent inhibitory activity against Gram-positive bacteria, are a group of oligosaccharide antibiotics produced by Streptomyces viridochromogenes . Among these structurally related oligosaccharide antibiotics, avilamycin A serves as the main bioactive component in veterinary drugs and animal feed additives, which differs from avilamycin C only in the redox state of the two-carbon branched-chain of the terminal octose moiety. However, the mechanisms underlying assembly and modification of the oligosaccharide chain to diversify individual avilamycins remain poorly understood. Here, we report that AviZ1, an aldo-keto reductase in the avilamycin pathway, can catalyze the redox conversion between avilamycins A and C . Remarkably, the ratio of these two components produced by AviZ1 depends on the utilization of specific redox cofactors, namely NADH/NAD + or NADPH/NADP + . These findings are inspired by gene disruption and complementation experiments and are further supported by in vitro enzymatic activity assays, kinetic analyses, and cofactor affinity studies on AviZ1-catalyzed redox reactions. Additionally, the results from sequence analysis, structure prediction, and site-directed mutagenesis of AviZ1 validate it as an NADH/NAD + -favored aldo-keto reductase that primarily oxidizes avilamycin C to form avilamycin A by utilizing abundant NAD + in vivo . Building upon the biological function and catalytic activity of AviZ1, overexpressing AviZ1 in S. viridochromogenes is thus effective to improve the yield and proportion of avilamycin A in the fermentation profile of avilamycins. This study represents, to our knowledge, the first characterization of biochemical reactions involved in avilamycin biosynthesis and contributes to the construction of high-performance strains with industrial value. IMPORTANCE Avilamycins are a group of oligosaccharide antibiotics produced by Streptomyces viridochromogenes , which can be used as veterinary drugs and animal feed additives. Avilamycin A is the most bioactive component, differing from avilamycin C only in the redox state of the two-carbon branched-chain of the terminal octose moiety. Currently, the biosynthetic pathway of avilamycins is not clear. Here, we report that AviZ1, an aldo-keto reductase in the avilamycin pathway, can catalyze the redox conversion between avilamycins A and C . More importantly, AviZ1 exhibits a unique NADH/NAD + preference, allowing it to efficiently catalyze the oxidation of avilamycin C to form avilamycin A using abundant NAD + in cells. Thus, overexpressing AviZ1 in S. viridochromogenes is effective to improve the yield and proportion of avilamycin A in the fermentation profile of avilamycins. This study serves as an enzymological guide for rational strain design, and the resulting high-performance strains have significant industrial value.

Deciphering the Biosynthesis of TDP--L-oleandrose in Avermectin

Guvermectin Biosynthesis Revealing the Key Role of a Phosphoribohydrolase and Structural Insight into the Active Glutamate of a Noncanonical Adenine Phosphoribosyltransferase

Positive Regulation of Avermectin Biosynthesis by AveR in Streptomyces Avermitilis

Characterization of a C3 Deoxygenation Pathway Reveals a Key Branch Point in Aminoglycoside Biosynthesis

Synthetic Biology of Avermectin for Production Improvement and Structure Diversification

Redox Modifications in the Biosynthesis of Alchivemycin A Enable the Formation of Its Key Pharmacophore

Direct Proteomic Mapping of Streptomyces Avermitilis Wild and Industrial Strain and Insights into Avermectin Production

AvmM catalyses macrocyclization through dehydration/Michael-type addition in alchivemycin A biosynthesis

Overexpression of the ABC Transporter AvtAB Increases Avermectin Production in Streptomyces Avermitilis.

[Comparative metabolomics analysis of metabolic pathways in the high-yielding mutant strain of avilamycin]

Research progress of avermectin: A minireview based on the structural derivatization of avermectin

Complete In Vitro Reconstitution of the Apramycin Biosynthetic Pathway Demonstrates the Unusual Incorporation of a β-d-Sugar Nucleotide in the Final Glycosylation Step

Effects of amino acid precursor on the avermectin biosythesis

Efficient biosynthesis of nucleoside cytokinin angustmycin A containing an unusual sugar system

Heterologous Expression of Avermectins Biosynthetic Gene Cluster by Construction of a Bacterial Artificial Chromosome Library of the Producers

Acyltransferase Domain Swapping for the Production of Tenvermectin B Metabolites in Genetically Engineered Strain Streptomyces avermitilis HU02

Interrogation of Streptomyces avermitilis for efficient production of avermectins.

An NADH/NAD+-favored aldo-keto reductase facilitates avilamycin A biosynthesis by primarily catalyzing oxidation of avilamycin C

Enhancement of acyl‐CoA precursor supply for increased avermectin B1a production by engineering meilingmycin polyketide synthase and key primary metabolic pathway genes

Avermectin B1a production in Streptomyces avermitilis is enhanced by engineering aveC and precursor supply genes

Lanthipeptide Synthetases Participate the Biosynthesis of 2-Aminovinyl-cysteine Motifs in Thioamitides